Loading clinical trials...
Loading clinical trials...
68Ga-AAZTA-093 is a novel radiotracer incorporating a hypoxia sensitive nitroimidazole(NI)-moiety and a PSMA-targeting. In this study, we observed the safety, biodistribution, radiation dosimetry and ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
First Affiliated Hospital of Fujian Medical University
NCT06844383 · Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer)
NCT07332000 · Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma)
NCT06616597 · Prostate Cancer (Adenocarcinoma), Metastatic Prostate Cancer
NCT07115914 · Prostate Cancer (Adenocarcinoma), Prostate Cancer (Diagnosis), and more
NCT07407608 · Prostate Cancer, Prostate Cancer (Adenocarcinoma), and more
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions